estrogen
PEP seems to offer a       potential for revival of the most cost-effective endocrine treatment of cancer of       the prostate, i.e., estrogen.
PEP seems to offer a       potential for revival of the most cost-effective endocrine  @PREDICAT$  of  @OBJECT$  of       the prostate, i.e.,  @SUBJECT$ .